image
Enliven Therapeutics, Inc. ELVN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 24.41
-2.05 %
$ 1.19 B
Market Cap
-13.05
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% -89.63% -115.33%
Annual Report FY 10-K 2022-12-31 0.00% -52.72% -56.66%
Annual Report FY 10-K 2021-12-31 0.00% -30.54% -165.74%
Annual Report FY 10-K 2020-12-31 0.00% 19.30% 61.36%
Annual Report FY 10-K 2019-12-31 0.00% -106.96% -125.87%
Annual Report FY 10-K 2018-12-31 0.00% 0.00% -19.90%
Annual Report FY 10-K 2017-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -11.49% -11.63%
Quarterly Report Q2 8-K 2024-06-30 0.00% -19.31% -22.20%
Quarterly Report Q1 8-K 2024-03-31 0.00% -74.50% -58.28%
Quarterly Report Q4 8-K 2023-12-31 0.00% -60.18% -597.85%
Quarterly Report Q3 8-K 2023-09-30 0.00% -96.79% -121.77%
Quarterly Report Q2 8-K 2023-06-30 0.00% -88.11% -123.31%
Quarterly Report Q1 8-K 2023-03-31 0.00% -50.31% -89.19%
Quarterly Report Q4 8-K 2022-12-31 0.00% 483.52% 61.20%
Quarterly Report Q3 8-K 2022-09-30 0.00% 22.66% 19.95%
Quarterly Report Q2 8-K 2022-06-30 0.00% 32.46% 31.54%
Quarterly Report Q1 8-K 2022-03-31 0.00% 15.48% 15.58%
Quarterly Report Q4 8-K 2021-12-31 0.00% 27.14% 27.32%
Quarterly Report Q3 8-K 2021-09-30 0.00% -9.85% -9.32%
Quarterly Report Q2 8-K 2021-06-30 0.00% -28.98% -27.83%
Quarterly Report Q1 8-K 2021-03-31 0.00% -42.16% -39.83%
Quarterly Report Q4 8-K 2020-12-31 0.00% -58.87% -54.35%
Quarterly Report Q3 8-K 2020-09-30 0.00% -87.60% -81.55%
Quarterly Report Q2 8-K 2020-06-30 0.00% -89.07% -85.39%
Quarterly Report Q1 8-K 2020-03-31 0.00% -72.03% -75.30%
Quarterly Report Q4 8-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2019-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2019-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2019-03-31 0.00% 0.00% 0.00%